Submission Details
| 510(k) Number | K993332 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 04, 1999 |
| Decision Date | February 16, 2000 |
| Days to Decision | 135 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K993332 is an FDA 510(k) clearance for the GRADIPLASMA LA HIGH, GRADIPLASMA LA LOW MODELS LAHP-1, LAHP-05, LALP-1, LALP-05, a Control, Plasma, Abnormal (Class II — Special Controls, product code GGC), submitted by Gradipore , Ltd. (North Ryde, AU). The FDA issued a Cleared decision on February 16, 2000, 135 days after receiving the submission on October 4, 1999. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5425.
| 510(k) Number | K993332 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 04, 1999 |
| Decision Date | February 16, 2000 |
| Days to Decision | 135 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GGC — Control, Plasma, Abnormal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.5425 |